- Home
- KALA vs ISPC Comparison
KALA vs ISPC Comparison
Compare KALA & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- ISPC
- Stock Information
- Founded
- KALA 2009
- ISPC 2009
- Country
- KALA United States
- ISPC United States
- Employees
- KALA N/A
- ISPC N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- ISPC Precision Instruments
- Sector
- KALA Health Care
- ISPC Health Care
- Exchange
- KALA Nasdaq
- ISPC Nasdaq
- Market Cap
- KALA 5.1M
- ISPC 5.7M
- IPO Year
- KALA 2017
- ISPC 2021
- Fundamental
- Price
- KALA $0.89
- ISPC $0.50
- Analyst Decision
- KALA Buy
- ISPC
- Analyst Count
- KALA 3
- ISPC 0
- Target Price
- KALA $31.50
- ISPC N/A
- AVG Volume (30 Days)
- KALA 1.6M
- ISPC 181.0K
- Earning Date
- KALA 11-19-2025
- ISPC 11-17-2025
- Dividend Yield
- KALA N/A
- ISPC N/A
- EPS Growth
- KALA N/A
- ISPC N/A
- EPS
- KALA N/A
- ISPC N/A
- Revenue
- KALA N/A
- ISPC $3,352,744.00
- Revenue This Year
- KALA N/A
- ISPC $35.93
- Revenue Next Year
- KALA N/A
- ISPC N/A
- P/E Ratio
- KALA N/A
- ISPC N/A
- Revenue Growth
- KALA N/A
- ISPC N/A
- 52 Week Low
- KALA $0.61
- ISPC $0.39
- 52 Week High
- KALA $20.60
- ISPC $4.66
- Technical
- Relative Strength Index (RSI)
- KALA 39.51
- ISPC 33.11
- Support Level
- KALA $0.61
- ISPC $0.39
- Resistance Level
- KALA $0.70
- ISPC $0.51
- Average True Range (ATR)
- KALA 0.09
- ISPC 0.06
- MACD
- KALA 0.25
- ISPC -0.00
- Stochastic Oscillator
- KALA 70.38
- ISPC 36.42
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.